Peroxisome proliferator-activated receptor gamma agonists and the treatment of HIV-associated lipoatrophy: unraveling the molecular mechanism of their shortcomings

J Infect Dis. 2008 Dec 15;198(12):1729-31. doi: 10.1086/593180.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • HIV-Associated Lipodystrophy Syndrome / chemically induced*
  • HIV-Associated Lipodystrophy Syndrome / drug therapy*
  • Humans
  • PPAR gamma / agonists*

Substances

  • Anti-HIV Agents
  • PPAR gamma